Your session is about to expire
← Back to Search
Vestibulectomy Techniques for Vulvodynia
N/A
Recruiting
Led By Catherine Leclair, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Prior vestibulectomy or hymen surgery
Prior or current use of testosterone dosed for gender affirmation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline visit to 3 months after surgery
Awards & highlights
No Placebo-Only Group
Summary
This trial is comparing two different surgical techniques for treating a condition called vestibulodynia.
Who is the study for?
This trial is for adults over 18 with vulvodynia, experiencing tenderness in the vestibule area for at least 3 months. Participants must have a certain level of pain during cotton swab and tampon tests, access to phone and internet, and be willing to undergo pelvic floor physical therapy. Those who've had previous vestibulectomy or hymen surgery, use testosterone for gender affirmation, are pregnant, or have other causes of dyspareunia like endometriosis can't join.
What is being tested?
The study compares two surgical techniques used in vestibulectomy (surgery for vulvodynia) - the Traditional Technique versus a Modified Technique. The goal is to see which method provides better outcomes for patients suffering from this condition.
What are the potential side effects?
While specific side effects aren't listed here, common risks associated with surgical procedures may include infection, bleeding, pain at the incision site, scarring and potential changes in sexual sensation.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had surgery on my vestibule or hymen.
Select...
I am currently using or have used testosterone for gender affirmation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline visit to 3 months after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline visit to 3 months after surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Tampon Test pain scores from baseline to 3 months
Change in pain scores from baseline to 12 months
Change in pain scores from baseline to 6 months
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Traditional VestibulectomyActive Control1 Intervention
Group II: Modified VestibulectomyActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
1,008 Previous Clinical Trials
7,414,071 Total Patients Enrolled
3 Trials studying Vulvodynia
96 Patients Enrolled for Vulvodynia
Catherine Leclair, MDPrincipal InvestigatorOregon Health and Science University
3 Previous Clinical Trials
127 Total Patients Enrolled
2 Trials studying Vulvodynia
77 Patients Enrolled for Vulvodynia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 18, not pregnant, and have had pain in the vulvar area for at least 3 months.I am willing to participate in pelvic floor physical therapy.I have had surgery on my vestibule or hymen.I experience pain during intercourse due to conditions like endometriosis or skin issues.I am currently using or have used testosterone for gender affirmation.
Research Study Groups:
This trial has the following groups:- Group 1: Traditional Vestibulectomy
- Group 2: Modified Vestibulectomy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.